Citations (84)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Muhammad Shahbaz Aslam, Iram Gull, Malik Siddique Mahmood, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed & Muhammad Amin Athar. (2020) High yield expression, characterization, and biological activity of IFNα2-Tα1 fusion protein. Preparative Biochemistry & Biotechnology 50:3, pages 281-291.
Read now
Read now
Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, Lasse Kjær, Thomas Stauffer Larsen, Ole Weis Bjerrum, Torben A Kruse & Hans Carl Hasselbalch. (2017) The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms. Leukemia & Lymphoma 58:8, pages 1914-1921.
Read now
Read now
Roberto Latagliata, Angela Romano, Marco Mancini, Massimo Breccia, Ida Carmosino, Federico Vozella, Chiara Montagna, Paola Volpicelli, Federico De Angelis, Luigi Petrucci, Alessandra Serrao, Matteo Molica, Adriano Salaroli, Daniela Diverio & Giuliana Alimena. (2016) Discontinuation of alpha-interferon treatment in patients with chronic myeloid leukemia in long-lasting complete molecular response. Leukemia & Lymphoma 57:1, pages 99-102.
Read now
Read now
Mehrdad Talebian Yazdi, Kevin R Keene, Pieter S Hiemstra & Sjoerd H van der Burg. (2014) Recent progress in peptide vaccination in cancer with a focus on non-small-cell lung cancer. Expert Review of Vaccines 13:1, pages 87-116.
Read now
Read now
Vibe Skov, Caroline Hasselbalch Riley, Mads Thomassen, Thomas Stauffer Larsen, Morten K. Jensen, Ole Weis Bjerrum, Torben A. Kruse & Hans Carl Hasselbalch. (2013) Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis. Leukemia & Lymphoma 54:10, pages 2269-2273.
Read now
Read now
Tatsuaki Mizutani, Nina Neugebauer, Eva M. Putz, Nadine Moritz, Olivia Simma, Eva Zebedin-Brandl, Dagmar Gotthardt, Wolfgang Warsch, Eva Eckelhart, Hans-Peter Kantner, Ulrich Kalinke, Stefan Lienenklaus, Siegfried Weiss, Birgit Strobl, Mathias Müller, Veronika Sexl & Dagmar Stoiber. (2012) Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance. OncoImmunology 1:7, pages 1027-1037.
Read now
Read now
Hans Carl Hasselbalch. (2011) A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Expert Review of Hematology 4:6, pages 637-655.
Read now
Read now
Paola Rizza, Imerio Capone, Franca Moretti, Enrico Proietti & Filippo Belardelli. (2011) IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use. Expert Review of Vaccines 10:4, pages 487-498.
Read now
Read now
Articles from other publishers (76)
Xinhuai Dong, Can Lin, Xu Lin, Chong Zeng, Liming Zeng, Zibo Wei, Xiaokang Zeng & Jie Yao. (2023) Lactate inhibits interferon-α response in ovarian cancer by inducing STAT1 ubiquitin degradation. International Immunopharmacology 125, pages 111099.
Crossref
Crossref
Hitesh Vasiyani, Bhumika Wadhwa & Rajesh Singh. (2023) Regulation of cGAS-STING signalling in cancer: Approach for combination therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:3, pages 188896.
Crossref
Crossref
Joerg Herrmann, Gagan Sahni, Andrea Gallardo, Aferdita Spahillari, Matthew Galsky, Thomas Eschenhagen, Wendy Schaffer, Tomas G. Neilan, Ghosh Ak, Teodora Donisan, Dinu Valentin Balanescu, Cezar Iliescu, Keith Stewart & Carolyn Larsen. 2023. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease
451
506
.
Noralvis Fleitas-Salazar, Emilio Lamazares, Seidy Pedroso-Santana, Tomás Kappes, Alain Pérez-Alonso, Ángela Hidalgo, Claudia Altamirano, Oliberto Sánchez, Katherina Fernández & Jorge R. Toledo. (2022) Long-term release of bioactive interferon-alpha from PLGA-chitosan microparticles: in vitro and in vivo studies. Biomaterials Advances 143, pages 213167.
Crossref
Crossref
Deqian Xie, Qifei Wang & Guangzhen Wu. (2022) Research progress in inducing immunogenic cell death of tumor cells. Frontiers in Immunology 13.
Crossref
Crossref
Evgenii Plotnikov & Vladimir Plotnikov. (2022) Antibacterial and Phagocytic Properties of a Novel Silver-Interferon
Complex. Anti-Infective Agents 20:4.
Crossref
Crossref
Xuexia Tian, Anhua Shi & Junzi Wu. (2022) Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor
Targeting. Anti-Cancer Agents in Medicinal Chemistry 22:12, pages 2255-2273.
Crossref
Crossref
Lawrence Kasherman, Derrick Ho Wai Siu, Rachel Woodford & Carole A. Harris. (2022) Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future. Cancers 14:6, pages 1406.
Crossref
Crossref
Nafiseh Erfanian, Afshin Derakhshani, Saeed Nasseri, Mohammad Fereidouni, Behzad Baradaran, Neda Jalili Tabrizi, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris & Hossein Safarpour. (2022) Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective. Biomedicine & Pharmacotherapy 146, pages 112558.
Crossref
Crossref
Jin-Quan Fan, Yu-Tao Miao, Ke-Cheng Lu, Guo-liang Chen, Bin-Bin Li, Qian-Ming Hong, Xin-Jun Yang, Ze-Yu Yan & Yi-Hong Chen. (2022) A IFI27 gene contributes to ER-stress mediated apoptosis and benefits for white spot syndrome virus infection in Litopenaeus vannamei. Fish & Shellfish Immunology 120, pages 180-189.
Crossref
Crossref
Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie‐Christine Claudepierre, Doris Schmitt, Christelle Remy‐Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring‐Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio & Karola Rittner. (2022) Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination. Clinical & Translational Immunology 11:5.
Crossref
Crossref
Xueqiong Meng, Yixiang Chen, Salvador Macip & Keith Leppard. (2021) PML-II regulates ERK and AKT signal activation and IFNα-induced cell death. Cell Communication and Signaling 19:1.
Crossref
Crossref
Hideyuki Takahashi, Reika Kawabata-Iwakawa, Shota Ida, Ikko Mito, Hiroe Tada & Kazuaki Chikamatsu. (2021) Upregulated glycolysis correlates with tumor progression and immune evasion in head and neck squamous cell carcinoma. Scientific Reports 11:1.
Crossref
Crossref
Muhammad Shahbaz Aslam, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito & Sammer-ul Hassan. (2021) Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials 14:12, pages 3318.
Crossref
Crossref
Alessandra Tesser, Alessia Pin, Elisabetta Mencaroni, Virginia Gulino & Alberto Tommasini. (2021) Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain. International Journal of Environmental Research and Public Health 18:11, pages 5585.
Crossref
Crossref
E. N. Suspitsin, R. K. Raupov, E. M. Kuchinskaya & M. M. Kostik. (2021) Analysis of interferon type I signature for differential
diagnosis of diseases of the immune system ( review of literature). Russian Clinical Laboratory Diagnostics 66:5, pages 279-284.
Crossref
Crossref
Xiaofan Lu, Caoyu Ji, Liyun Jiang, Yue Zhu, Yujie Zhou, Jialin Meng, Jun Gao, Tao Lu, Junmei Ye & Fangrong Yan. (2021) Tumour microenvironment‐based molecular profiling reveals ideal candidates for high‐grade serous ovarian cancer immunotherapy. Cell Proliferation 54:3.
Crossref
Crossref
Sara Vitale, Valentina Russo, Beatrice Dettori, Cecilia Palombi, Denis Baev, Enrico Proietti, Agnes Le Bon, Filippo Belardelli & Luigia Pace. (2021) Type I interferons induce peripheral T regulatory cell differentiation under tolerogenic conditions. International Immunology 33:2, pages 59-77.
Crossref
Crossref
Bo Deng, Yuli Lin, Yusheng Chen, Shuai Ma, Qian Cai, Wenji Wang, Bingji Li, Tingyan Liu, Peihui Zhou, Rui He & Feng Ding. (2020) Plasmacytoid dendritic cells promote acute kidney injury by producing interferon-α. Cellular & Molecular Immunology 18:1, pages 219-229.
Crossref
Crossref
Sofi Damjanovska, Carson Smith, Ismail Sayin, Christopher J. Burant, Stefan Gravenstein & David H. Canaday. (2021) Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines. Vaccine 39:5, pages 786-789.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
197
226
.
Meinolf Suttorp & Markus Metzler. 2021. Late Treatment Effects and Cancer Survivor Care in the Young. Late Treatment Effects and Cancer Survivor Care in the Young
189
205
.
Ana Marisa Chudzinski-Tavassi, Kátia Luciano Pereira Morais, Jean Gabriel de Souza & Roger Chammas. 2020. Evolving Trends in Kidney Cancer. Evolving Trends in Kidney Cancer.
Patrizia Mondello, Cristian Di Mirto, Salvatore Cuzzocrea, Carmela Arrigo, Michael Mian & Vincenzo Pitini. (2019) Interferon Alpha Has a Strong Anti-tumor Effect in Philadelphia-negative Myeloproliferative Neoplasms. Clinical Lymphoma Myeloma and Leukemia 19:8, pages e489-e495.
Crossref
Crossref
Lucia Masarova, Prithviraj Bose & Srdan Verstovsek. (2019) The Rationale for Immunotherapy in Myeloproliferative Neoplasms. Current Hematologic Malignancy Reports 14:4, pages 310-327.
Crossref
Crossref
Christelle Langevin, Pierre Boudinot & Bertrand Collet. (2019) IFN Signaling in Inflammation and Viral Infections: New Insights from Fish Models. Viruses 11:3, pages 302.
Crossref
Crossref
Hailong Ma, Wenyi Yang, Liming Zhang, Shuli Liu, Mei Zhao, Ge Zhou, Lizhen Wang, Shufang Jin, Zhiyuan Zhang & Jingzhou Hu. (2018) Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma. British Journal of Cancer 120:3, pages 317-330.
Crossref
Crossref
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte, Virginie Malard, Hamida Hammad, Patrick Baril, Thierry Benvegnu, Paul-Alain Jaffrès, Sander A. A. Kooijmans, Raymond Schiffelers, Stefan Lienenklaus, Patrick Midoux, Chantal Pichon, Karine Breckpot & Kris Thielemans. (2018) Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety. ACS Nano 12:10, pages 9815-9829.
Crossref
Crossref
Yiying Wang, Peifu Zhu, Jing Qiu, Jie Wang, Huijuan Zhu, Yinwei Zhu, Lige Zhang, Jie Zhu, Xingxiang Liu & Chen Dong. (2017) Identification and characterization of interferon signaling-related microRNAs in occult hepatitis B virus infection. Clinical Epigenetics 9:1.
Crossref
Crossref
Silvano Sozzani, Annalisa Del Prete & Daniela Bosisio. (2017) Dendritic cell recruitment and activation in autoimmunity. Journal of Autoimmunity 85, pages 126-140.
Crossref
Crossref
Kirsty RossRob J. Jones. (2017) Immune checkpoint inhibitors in renal cell carcinoma. Clinical Science 131:21, pages 2627-2642.
Crossref
Crossref
Daniela Klotz, Wolfgang Baumgärtner & Ingo Gerhauser. (2017) Type I interferons in the pathogenesis and treatment of canine diseases. Veterinary Immunology and Immunopathology 191, pages 80-93.
Crossref
Crossref
Amber Kaplan, Michelle W. Lee, Andrea J. Wolf, Jose J. Limon, Courtney A. Becker, Minna Ding, Ramachandran Murali, Ernest Y. Lee, George Y. Liu, Gerard C. L. Wong & David M. Underhill. (2017) Direct Antimicrobial Activity of IFN-β. The Journal of Immunology 198:10, pages 4036-4045.
Crossref
Crossref
Simone Wachholz, Alexandra Knorr, Leonie Mengert, Jennifer Plümper, Rainer Sommer, Georg Juckel & Astrid Friebe. (2017) Interleukin-4 is a participant in the regulation of depressive-like behavior. Behavioural Brain Research 326, pages 165-172.
Crossref
Crossref
Lena Müller, Petra Aigner & Dagmar Stoiber. (2017) Type I Interferons and Natural Killer Cell Regulation in Cancer. Frontiers in Immunology 8.
Crossref
Crossref
Andrew RH Shepherd, Emily Shepherd & Nicholas R Brook. (2017) Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Ashley J Shepherd, William G Mackay & Suzanne Hagen. (2017) Washout policies in long-term indwelling urinary catheterisation in adults. Cochrane Database of Systematic Reviews 2017:3.
Crossref
Crossref
Sarah L. Pogue, Tetsuya Taura, Mingying Bi, Yong Yun, Angela Sho, Glen Mikesell, Collette Behrens, Maya Sokolovsky, Hussein Hallak, Moti Rosenstock, Eric Sanchez, Haiming Chen, James Berenson, Anthony Doyle, Steffen Nock & David S. Wilson. (2016) Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity. PLOS ONE 11:9, pages e0162472.
Crossref
Crossref
Simone Wachholz, Manuela Eßlinger, Jennifer Plümper, Marie-Pierre Manitz, Georg Juckel & Astrid Friebe. (2016) Microglia activation is associated with IFN-α induced depressive-like behavior. Brain, Behavior, and Immunity 55, pages 105-113.
Crossref
Crossref
Xiaowen Tang, Yao-Hua Song, Aining Sun, Xiaming Zhu, Changgeng Ruan & Depei Wu. (2016) Successful Treatment of Relapsed Acute Myeloid Leukemia Without Chemotherapy. Journal of Clinical Oncology 34:13, pages e117-e119.
Crossref
Crossref
Andrew RH Shepherd, Emily Shepherd & Nicholas R Brook. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Y Zhong, H Tang, X Wang, Q Zeng, Y Liu, Xi Zhao, K Yu, H Shi, R Zhu & X Mao. (2016) Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis. Clinical and Experimental Immunology 183:3, pages 452-468.
Crossref
Crossref
Jiahe Li, Yiwei Ai, Lihua Wang, Pengcheng Bu, Charles C. Sharkey, Qianhui Wu, Brittany Wun, Sweta Roy, Xiling Shen & Michael R. King. (2016) Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. Biomaterials 76, pages 52-65.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. 2016. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
207
230
.
J C Roeser, S D Leach & F McAllister. (2015) Emerging strategies for cancer immunoprevention. Oncogene 34:50, pages 6029-6039.
Crossref
Crossref
Lorenzo Falchi, Kate J. Newberry & Srdan Verstovsek. (2015) New Therapeutic Approaches in Polycythemia Vera. Clinical Lymphoma Myeloma and Leukemia 15, pages S27-S33.
Crossref
Crossref
Kathleen C. F. Sheehan, Helen M. Lazear, Michael S. Diamond & Robert D. Schreiber. (2015) Selective Blockade of Interferon-α and -β Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection. PLOS ONE 10:5, pages e0128636.
Crossref
Crossref
Guido Antonelli, Carolina Scagnolari, Federica Moschella & Enrico Proietti. (2015) Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use. Cytokine & Growth Factor Reviews 26:2, pages 121-131.
Crossref
Crossref
Moshe Talpaz, Jessica Mercer & Rüdiger Hehlmann. (2015) The interferon-alpha revival in CML. Annals of Hematology 94:S2, pages 195-207.
Crossref
Crossref
Beatriz Abós, Rosario Castro, Aitor González Granja, Jeffrey J. Havixbeck, Daniel R. Barreda & Carolina Tafalla. (2015) Early Activation of Teleost B Cells in Response to Rhabdovirus Infection. Journal of Virology 89:3, pages 1768-1780.
Crossref
Crossref
H Hashimoto, R Ueda, K Narumi, Y Heike, T Yoshida & K Aoki. (2014) Type I IFN gene delivery suppresses regulatory T cells within tumors. Cancer Gene Therapy 21:12, pages 532-541.
Crossref
Crossref
David Schrama, Selma Ugurel, Antje Sucker, Cathrin Ritter, Marc Zapatka, Dirk Schadendorf & Jürgen Christian Becker. (2014) STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients. Frontiers in Medicine 1.
Crossref
Crossref
David J Marchant, Caroline L Bellac, Theo J Moraes, Samuel J Wadsworth, Antoine Dufour, Georgina S Butler, Leanne M Bilawchuk, Reid G Hendry, A Gordon Robertson, Caroline T Cheung, Julie Ng, Lisa Ang, Zongshu Luo, Karl Heilbron, Michael J Norris, Wenming Duan, Taylor Bucyk, Andrei Karpov, Laurent Devel, Dimitris Georgiadis, Richard G Hegele, Honglin Luo, David J Granville, Vincent Dive, Bruce M McManus & Christopher M Overall. (2014) A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity. Nature Medicine 20:5, pages 493-502.
Crossref
Crossref
Zhi-Rong Zhang & Yan-Chao Duan. (2014) Interferon Apha 2b for Treating Patients with JAK2V617F Positive Polycythemia Vera and Essential Thrombocytosis. Asian Pacific Journal of Cancer Prevention 15:4, pages 1681-1684.
Crossref
Crossref
Angelica M. Bello, Lianhu Wei, Beata Majchrzak-Kita, Noruê Salum, Meena K. Purohit, Eleanor N. Fish & Lakshmi P. Kotra. (2014) Small molecule mimetics of an interferon-α receptor interacting domain. Bioorganic & Medicinal Chemistry 22:3, pages 978-985.
Crossref
Crossref
Michele Malagola, Massimo Breccia, Cristina Skert, Valeria Cancelli, Simona Soverini, Ilaria Iacobucci, Federica Cattina, Anna Maria Liberati, Mario Tiribelli, Mario Annunziata, Elena Trabacchi, Antonio De Vivo, Fausto Castagnetti, Giovanni Martinelli, Miriam Fogli, Fabio Stagno, Gianmatteo Pica, Alessandra Iurlo, Patrizia Pregno, Elisabetta Abruzzese, Simonetta Pardini, Monica Bocchia, Sabina Russo, Ivana Pierri, Monia Lunghi, Sara Barulli, Serena Merante, Franco Mandelli, Giuliana Alimena, Gianatonio Rosti, Michele Baccarani & Domenico Russo. (2014) Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era. American Journal of Hematology 89:2, pages 119-124.
Crossref
Crossref
Rong-Juan Pei. (2014) Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World Journal of Gastroenterology 20:33, pages 11618.
Crossref
Crossref
Salma Hasan, Catherine Lacout, Caroline Marty, Marie Cuingnet, Eric Solary, William Vainchenker & Jean-Luc Villeval. (2013) JAK2V617F expression in mice amplifies early hematopoietic cells and gives them a competitive advantage that is hampered by IFNα. Blood 122:8, pages 1464-1477.
Crossref
Crossref
Stefania Parlato, Roberto Bruni, Paola Fragapane, Debora Salerno, Cinzia Marcantonio, Paola Borghi, Paola Tataseo, Anna Rita Ciccaglione, Carlo Presutti, Giulia Romagnoli, Irene Bozzoni, Filippo Belardelli & Lucia Gabriele. (2013) IFN-α Regulates Blimp-1 Expression via miR-23a and miR-125b in Both Monocytes-Derived DC and pDC. PLoS ONE 8:8, pages e72833.
Crossref
Crossref
Brady L. SteinRamon V. Tiu. (2013) Biological Rationale and Clinical Use of Interferon in the Classical BCR-ABL-Negative Myeloproliferative Neoplasms. Journal of Interferon & Cytokine Research 33:4, pages 145-153.
Crossref
Crossref
Ludvig M. Sollid & Bana Jabri. (2013) Triggers and drivers of autoimmunity: lessons from coeliac disease. Nature Reviews Immunology 13:4, pages 294-302.
Crossref
Crossref
Ya-wen Zheng, Hui Li, Jin-pu Yu, Hua Zhao, Shizhen Emily Wang & Xiu-bao Ren. (2013) Interferon-λs: Special Immunomodulatory Agents and Potential Therapeutic Targets. Journal of Innate Immunity 5:3, pages 209-218.
Crossref
Crossref
Andrea Sgorbissa & Claudio Brancolini. (2012) IFNs, ISGylation and cancer: Cui prodest?. Cytokine & Growth Factor Reviews 23:6, pages 307-314.
Crossref
Crossref
Eleonora AricòFilippo Belardelli. (2012) Interferon-α as Antiviral and Antitumor Vaccine Adjuvants: Mechanisms of Action and Response Signature. Journal of Interferon & Cytokine Research 32:6, pages 235-247.
Crossref
Crossref
José M. González-Navajas, Jongdae Lee, Michael David & Eyal Raz. (2012) Immunomodulatory functions of type I interferons. Nature Reviews Immunology 12:2, pages 125-135.
Crossref
Crossref
Eleonora Aricò, Luciano Castiello, Francesca Urbani, Paola Rizza, Monica C Panelli, Ena Wang, Francesco M Marincola & Filippo Belardelli. (2011) Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments. Journal of Translational Medicine 9:1.
Crossref
Crossref
E. Razzuoli, R. Villa, E. Sossi & M. Amadori. (2011) Reverse Transcription Real-Time PCR for Detection of Porcine Interferon α and β Genes. Scandinavian Journal of Immunology 74:4, pages 412-418.
Crossref
Crossref
Heather D. Marshall, Stina L. Urban & Raymond M. Welsh. (2011) Virus-Induced Transient Immune Suppression and the Inhibition of T Cell Proliferation by Type I Interferon. Journal of Virology 85:12, pages 5929-5939.
Crossref
Crossref
Kai Kisand, Desa Lilic, Jean-Laurent Casanova, Pärt Peterson, Anthony Meager & Nick Willcox. (2011) Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: Clinical and pathogenetic implications. European Journal of Immunology 41:6, pages 1517-1527.
Crossref
Crossref
Jean-Jacques KiladjianRuben A. Mesa & Ronald Hoffman. (2011) The renaissance of interferon therapy for the treatment of myeloid malignancies. Blood 117:18, pages 4706-4715.
Crossref
Crossref
Silvia Lorenzi, Fabrizio Mattei, Antonella Sistigu, Laura Bracci, Francesca Spadaro, Massimo Sanchez, Massimo Spada, Filippo Belardelli, Lucia Gabriele & Giovanna Schiavoni. (2011) Type I IFNs Control Antigen Retention and Survival of CD8α+ Dendritic Cells after Uptake of Tumor Apoptotic Cells Leading to Cross-Priming. The Journal of Immunology 186:9, pages 5142-5150.
Crossref
Crossref
Eleonora Aricò, Domenica M. Monque, Giuseppina D’Agostino, Federica Moschella, Massimo Venditti, Ulrich Kalinke, Deborah J. Allen, Anthony A. Nash, Filippo Belardelli & Maria Ferrantini. (2011) MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68. Vaccine 29:23, pages 3935-3944.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Oncology 23:2, pages 227-234.
Crossref
Crossref
Francesco Dituri, Antonio Mazzocca, Gianluigi Giannelli & Salvatore Antonaci. (2011) PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors. Clinical and Developmental Immunology 2011, pages 1-10.
Crossref
Crossref
Loredana Frasca & Roberto Lande. (2011) Overlapping, Additive and Counterregulatory Effects of Type II and I Interferons on Myeloid Dendritic Cell Functions. The Scientific World JOURNAL 11, pages 2071-2090.
Crossref
Crossref
Giorgio Trinchieri. (2010) Type I interferon: friend or foe?. Journal of Experimental Medicine 207:10, pages 2053-2063.
Crossref
Crossref